Patents by Inventor Robert Owen

Robert Owen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120155788
    Abstract: A zipper member type of closure mechanism is mounted to a bag by adhesive materials having contrasting characteristics selected for providing advantages. The closure mechanism is mounted proximate an opening of the bag, so that the closure mechanism is positioned for use in opening and closing the bag.
    Type: Application
    Filed: September 19, 2011
    Publication date: June 21, 2012
    Applicant: GRAPHIC PACKING INTERNATIONAL, INC.
    Inventors: Michael L. Iannelli, II, Robert Owens
  • Publication number: 20120156050
    Abstract: A rotor blade having a detachable fairing is disclosed. The rotor blade includes leading and trailing edge fairings secured to the blade spar and one or more control lines extending between of the fairings and the blade spar. A detachable fairing extends from one or both of the leading and trailing edge fairings toward one of the distal and proximal ends of the blade spar. The detachable fairing and blade spar form an airfoil contour. The detachable fairing may secure to a tip jet attachment fitting at a distal end of the blade spar. A mounting structure including upper and lower plates may secure near a proximal end of the blade spar and the detachable fairing may secure to both the upper and lower plates to form all or part of an airfoil contour. The mounting structure may include a spherical seat engaging a spherical surface of a hub shroud.
    Type: Application
    Filed: October 27, 2011
    Publication date: June 21, 2012
    Applicant: GROEN BROTHERS AVIATION, INC
    Inventor: Robert Owen White
  • Publication number: 20120126451
    Abstract: The present invention relates to molds used to manufacture concrete block having customizable color and textures. The present invention also relates to the methods of making the molds and to methods of manufacturing the substitute blocks.
    Type: Application
    Filed: November 22, 2011
    Publication date: May 24, 2012
    Inventor: Robert A. Owen
  • Publication number: 20120111997
    Abstract: An aircraft is disclosed having an engine and a propeller mounted to a fuselage. An empennage mounts to the aircraft and includes first and second horizontal stabilizers separated by a distance greater than the diameter of a stream tube of the propeller at the horizontal stabilizers. A rudder extends between the horizontal stabilizers and is positioned within the stream tube of the propeller. The rudder may mount to a first vertical stabilizer extending between the horizontal stabilizers. The horizontal stabilizers may be secured to second and third vertical stabilizers to form a duct having the rudder positioned within the duct. Additional rudders may mount to the second and third vertical stabilizers.
    Type: Application
    Filed: January 12, 2012
    Publication date: May 10, 2012
    Applicant: GROEN BROTHERS AVIATION, INC
    Inventor: Robert Owen White
  • Publication number: 20120108557
    Abstract: The present invention relates to fluoroquinolone derivatives having enhanced ocular penetration characteristics and/or antimicrobial activity, and to compositions comprising such derivatives. The derivatives and compositions are particularly well suited for treating ophthalmic bacterial infections. The present invention more particularly relates to the discovery that a 2-methyl substitution on a diazabicyclo group attached to a fluoroquinolone ring system produces improved permeability characteristics, and that a 5-amino substitution on a fluoroquinolone ring system results in improved anti-microbial activity.
    Type: Application
    Filed: January 13, 2012
    Publication date: May 3, 2012
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Geoffrey Robert Owen, Amy C. Brooks, Lina F. Bernal-Perez, David W. Stroman, Joseph J. Dajcs
  • Publication number: 20120056426
    Abstract: A wind turbine has a rotor with a hub that houses a remote sensing device such as a Lidar for each blade. Each Lidar has one or more look directions that extend generally radially along the respective blade in front of the blade. The Lidar has multiple range gates and wind parameters sensed at each range may be used to control surfaces on the blade such as a trailing edge flap.
    Type: Application
    Filed: February 2, 2010
    Publication date: March 8, 2012
    Inventors: Gijsbertus Arnoldus Maria Van Kuik, Robert Owen Bowyer, Kelvin Beverley Hales
  • Publication number: 20120053846
    Abstract: Versions of the invention are directed to methods and apparatus for a new type of association-based linkage study technique using bi-allelic markers. The markers used in this technique are chosen so that the least common allele frequencies of the markers vary systematically over a range or subrange of least common allele frequency and the chromosomal location of the markers vary systematically over one or more chromosomal regions or chromosomes to achieve a systematic distribution of the markers over a two-dimensional region that has the orthogonal dimensions of chromosomal location and least common allele frequency. By using the two characteristics or two dimensions of marker chromosomal location and marker allele population frequency in this way, the power and systematic nature of genetic linkage studies using association-based linkage tests is greatly increased. These two-dimensional linkage study techniques increase the power of association studies to localize trait-causing polymorphisms of modest effect.
    Type: Application
    Filed: September 23, 2011
    Publication date: March 1, 2012
    Inventors: Ralph Evan McGinnis, Robert Owen McGinnis
  • Publication number: 20120053844
    Abstract: Versions of the invention are directed to methods and apparatus for a new type of association-based linkage study technique using bi-allelic markers. The markers used in this technique are chosen so that the least common allele frequencies of the markers vary systematically over a range or subrange of least common allele frequency and the chromosomal location of the markers vary systematically over one or more chromosomal regions or chromosomes to achieve a systematic distribution of the markers over a two-dimensional region that has the orthogonal dimensions of chromosomal location and least common allele frequency. By using the two characteristics or two dimensions of marker chromosomal location and marker allele population frequency in this way, the power and systematic nature of genetic linkage studies using association-based linkage tests is greatly increased. These two-dimensional linkage study techniques increase the power of association studies to localize trait-causing polymorphisms of modest effect.
    Type: Application
    Filed: September 13, 2011
    Publication date: March 1, 2012
    Inventors: Ralph Evan McGinnis, Robert Owen McGinnis
  • Publication number: 20120054624
    Abstract: An automatically provisioned virtual private data center provided on a cloud network of multiple virtual private data centers that reside in one or more physical data centers and may migrate between multiple physical data centers. The VPDC is a encapsulated virtual structure provisioned according to customer selected options within a virtual data center having one or more foundation nodes. Different service profiles are provided in a provisioning interface to the customer, each defining several configuration specifics that are used to automatically provision a VPDC for the customer.
    Type: Application
    Filed: August 27, 2010
    Publication date: March 1, 2012
    Inventors: Kenneth Robert OWENS, JR., Bryan Samuel DOERR, John Chi YUNG
  • Patent number: 8083913
    Abstract: An electrochemical cell for testing the electrochemical behavior of a plurality of materials comprises: a first electrode; a counter-electrode bearing an electrochromic material having a visual or measurable property which changes in a manner proportional to the total charge passed through it; and an electrolyte between and in electrical contact with the first electrode and the counter-electrode; wherein one of the first electrode and the electrolyte comprises a plurality of regions, each region comprising a sample of material to be tested, the regions being, in the case of the first electrode, electrically connected to a common terminal. Such a cell can be used for a “combinatorial chemistry” approach to testing the properties of possible cell components.
    Type: Grant
    Filed: January 9, 2004
    Date of Patent: December 27, 2011
    Assignee: University of Southampton
    Inventors: John Robert Owen, Philip Nigel Bartlett, Brian Elliot Hayden, Andrea Elizabeth Russell, Karen Marie Brace
  • Patent number: 8063188
    Abstract: Monoclonal anti-myostatin antibodies that preferentially bind myostatin over GDF-11, have strong binding affinity to myostatin and are resistant to chemical degradation. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for the treatment or prevention of various disorders in mammalian and avian species.
    Type: Grant
    Filed: August 23, 2007
    Date of Patent: November 22, 2011
    Assignee: Eli Lilly and Company
    Inventors: Robert Owen Sayers, Lihua Huang
  • Publication number: 20110278728
    Abstract: An electronic device package comprising: a block of insulating material; an electronic device housed within the insulating material and having a set of contact pads thereon; and a set of electrically conductive contact members at least partially housed within the insulating material, each contact member extending between a respective external contact point at which it is exposed at the surface of the block and an internal contact point from which it is electrically coupled to a respective contact pad on the electronic device, each internal contact point being outside the footprint of the electronic device, the set of contact members including: at least one contact member of a first type whose external contact point is located at least partially within the footprint of the electronic device; and at least one contact member of a second type that is wholly outside the footprint of the device.
    Type: Application
    Filed: October 20, 2008
    Publication date: November 17, 2011
    Applicant: CAMBRIDGE SILICON RADIO LIMITED
    Inventors: Martyn Robert Owen, Andrew George Holland
  • Publication number: 20110236876
    Abstract: A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.
    Type: Application
    Filed: June 8, 2011
    Publication date: September 29, 2011
    Applicant: CARIDIANBCT BIOTECHNOLOGIES, LLC
    Inventors: Robert Owen LOCKERBIE, Vijay KUMAR, Shawn D. KEIL, Raymond P. GOODRICH
  • Publication number: 20110224273
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Application
    Filed: September 9, 2010
    Publication date: September 15, 2011
    Applicant: AstraZeneca AB
    Inventors: Martin John Packer, James Stewart Scott, Andrew Stocker, Paul Robert Owen Whittamore
  • Patent number: 8017110
    Abstract: A process for damaging and maintaining damage to the nucleic acids of pathogens such as white blood cells, bacteria and viruses which may be contained in blood or blood components. This process comprises adding to the blood or blood component containing pathogens an effective amount of riboflavin, and exposing the fluid to light of an appropriate wavelength to damage the nucleic acid of the pathogen and to substantially maintain the damage to the pathogenic nucleic acids to allow for subsequent transfusion into a recipient.
    Type: Grant
    Filed: June 8, 2011
    Date of Patent: September 13, 2011
    Assignee: CaridianBCT Biotechnologies, LLC
    Inventors: Raymond P. Goodrich, Shawn D. Keil, Robert Owen Lockerbie, Vijay Kumar
  • Patent number: 8017270
    Abstract: An electrochemical cell comprising a cathode, an anode and an electrolyte is provided, wherein: the cathode comprises mesoporous nickel having a periodic arrangement of substantially uniformly sized pores of cross-section of the order of 10?8 to 10?9 m; and the anode comprises a mesoporous material having a periodic arrangement of substantially uniformly sized pores of cross-section of the order of 10?8 to 10?9 m and selected from: carbon, cadmium, iron, a palladium/nickel alloy, an iron/titanium alloy, palladium or a mixed metal hydride.
    Type: Grant
    Filed: December 12, 2003
    Date of Patent: September 13, 2011
    Assignee: University of Southampton
    Inventors: Philip Nigel Bartlett, John Robert Owen, Phillip A Nelson
  • Publication number: 20110160172
    Abstract: The present invention relates to fluoroquinolone derivatives having enhanced ocular penetration characteristics and/or antimicrobial activity, and to compositions comprising such derivatives. The derivatives and compositions are particularly well suited for treating ophthalmic bacterial infections. The present invention more particularly relates to the discovery that a 2-methyl substitution on a diazabicyclo group attached to a fluoroquinolone ring system produces improved permeability characteristics, and that a 5-amino substitution on a fluoroquinolone ring system results in improved anti-microbial activity.
    Type: Application
    Filed: March 8, 2011
    Publication date: June 30, 2011
    Applicant: ALCON RESEARCH, LTD.
    Inventors: Geoffrey Robert Owen, Amy C. Brooks, Lina Bernal-Perez, David W. Stroman, Joseph J. Dajcs
  • Patent number: 7964618
    Abstract: Compounds of formula (I): wherein variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are described.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: June 21, 2011
    Assignee: AstraZeneca AB
    Inventors: William McCoull, Martin Packer, James Stewart Scott, Paul Robert Owen Whittamore
  • Patent number: 7951833
    Abstract: New crystalline forms of 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described.
    Type: Grant
    Filed: February 3, 2009
    Date of Patent: May 31, 2011
    Assignee: AstraZeneca AB
    Inventors: Gary Peter Tomkinson, Martin John Packer, James Stewart Scott, Paul Robert Owen Whittamore, Andrew Stocker
  • Publication number: 20110092526
    Abstract: A compound of formula (I): and pharmaceutically-acceptable salts thereof, wherein the variable groups are defined within; their use in the inhibition of 11?HSD1, processes for making them and pharmaceutical compositions comprising them are also described herein.
    Type: Application
    Filed: October 19, 2010
    Publication date: April 21, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Stuart Norman Lile Bennett, Frederick Woolf Goldberg, Andrew Leach, Paul Robert Owen Whittamore, Pernilla Sörme